1. Andreev, V.V., Podunov, A.Yu., Lapin, D.S., et al., Clinical and pathogenetic peculiarities of cerebral stroke in patients with the new coronavirus infection (COVID-19), Regionarnoe krovoobrashchenie i mikrotsirkulyatsiya, 2020, vol. 19, no. 3, pp. 46–56.
2. Belopasov, V.V., Yashu, Ya., Samoilova, E.M., and Baklaushev, V.P., Damage to the nervous system in COVID-19, Klin. Praktika, 2020, vol. 11, no. 2, pp. 60–80.
3. Bondar’, S.A., Maslyanskii, A.L., Smirnova, A.Yu., et al., Guillain–Barré syndrome and COVID-19: clinical observations, Ros. Med. Zh., 2021, no. 5, pp. 60–64.
4. Vremennye metodicheskie rekomendatsii Minzdrava Rossii “Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19) (Interim Guidelines of the Ministry of Health of Russia “Prophylaxis, Diagnostics and Treatment of the New Coronavirus Infection (COVID-19)”), Versiya-13 (October 14, 2021), Moscow, 2021, р. 5. https://static0.minzdrav.gov.ru/system/attachments/attaches/000/058/075/original/%D0%92%D0%9C%D-0%A0_COVID-19_V13.-pdf COVID-19_v13.
5. Gromova, O.A., Torshin, I.Yu., Semenov, V.A., et al., On direct and indirect neurological manifestations of COVID-19, Zh. Nevrol. Psikhiatr. im. S.S. Korsakova, 2020, vol. 120, no. 11, pp. 11–21.